Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Celsius Therapeutics gains rights to Harbour Antibodies' antibody discovery platform

June 4, 2018

GSK, Cloud Pharmaceuticals form drug discovery collaboration

May 31, 2018

KRAS-G12C inhibitors reveal new approach to undruggable targets

May 22, 2018

Emulate and AstraZeneca enter Organs-on-Chips technology agreement

May 17, 2018

Lodo Therapeutics and Genentech enter multi-target strategic collaboration

May 10, 2018

XtalPi and Pfizer enter research collaboration

May 9, 2018

Alnylam achieves delivery of siRNA conjugates to CNS

May 9, 2018

Boehringer Ingelheim and Topas Therapeutics enter research agreement

April 25, 2018

Mercaptor develops new class of drugs called captons

April 19, 2018

Injectable hydrogel releases corticosteroid in response to arthritis flares

April 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...